The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
申请公布号
CA2615022(A1)
申请公布日期
2007.02.08
申请号
CA20062615022
申请日期
2006.07.14
申请人
MERCK & CO., INC.
发明人
LIVERTON, NIGEL J.;HOLLOWAY, M. KATHARINE;LUDMERER, STEVEN W.;MCCAULEY, JOHN A.;RUDD, MICHAEL T.;OLSEN, DAVID B.;VACCA, JOSEPH P.;MCINTYRE, CHARLES J.
